Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    paget's disease of bone
Show Display Options
RSS Create an RSS feed from your search for:
paget's disease of bone
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pathophysiology of Paget's Disease of Bone
Condition: Paget's Disease of Bone
Intervention:
2 Completed Genetic Study of Families Affected by Paget's Disease of Bone
Condition: Paget's Disease of Bone
Intervention:
3 Recruiting Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Conditions: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia;   Paget Disease of Bone;   Frontotemporal Dementia;   Myopathy
Intervention:
4 Completed Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
Condition: Paget's Disease of Bone
Intervention: Drug: Zoledronic acid
5 Completed 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
Condition: Paget's Disease of Bone
Intervention: Drug: Bisphosphonate treatment
6 Completed
Has Results
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
Condition: Paget's Disease of Bone
Interventions: Drug: zoledronic acid;   Drug: placebo to zoledronic acid;   Drug: Risedronate;   Drug: Placebo to risedronate;   Drug: Calcium and vitamin D supplements
7 Completed A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
Condition: Paget's Disease of Bone
Intervention: Drug: alendronate
8 Completed
Has Results
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
Condition: Paget's Disease of Bone
Interventions: Drug: Zoledronic Acid;   Drug: Risedronate;   Drug: Placebo to Risedronate;   Drug: Placebo to Zoledronic Acid;   Dietary Supplement: Calcium and Vitamin D
9 Active, not recruiting Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance −
Condition: Osseous Paget's Disease
Intervention: Drug: Sodium risedronate
10 Completed Re-treatment of Patients With Paget's Disease Using Zoledronic Acid
Condition: Paget's Disease of the Bone
Intervention: Drug: Zoledronic Acid
11 Completed
Has Results
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone;   Hypocalcemia
Interventions: Drug: Reclast (ZOL446, zoledronic acid);   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
12 Completed
Has Results
Bisphosphonate Therapy for Osteogenesis Imperfecta
Conditions: Osteogenesis Imperfecta;   Osteoporosis;   Paget Disease of Bone
Interventions: Drug: Alendronate;   Drug: Pamidronate
13 Recruiting Characterization of Familial Myopathy and Paget Disease of Bone
Conditions: Muscle Disorder;   Bone Disorder
Intervention: Device: Diffuse Optical Spectroscopy
14 Terminated Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
Conditions: Osteosarcoma;   Paget's Disease
Intervention:
15 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
Intervention:
16 Recruiting A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)
Condition: Low Bone Mass in Anorexia Nervosa Patients
Intervention: Drug: osteoanabolic therapy
17 Recruiting Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV NSCLC
Condition: NSCLC
Intervention: Drug: Zoledronic acid
18 Terminated Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Conditions: Osteosarcoma;   Paget's Disease;   Ewing Sarcoma
Intervention: Other: DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI
19 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
20 Completed Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
Conditions: Osteoporosis;   Thalassemia Major;   Thalassemia Intermedia
Intervention: Drug: Neridronate

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years